Evaluation of the Antibacterial Activity of Quinoxaline Derivative Compound Against Methicillin-Resistant Staphylococcus aureus

References

• Bartels MD, Worning P, Andersen LP, et al. Repeated introduction and spread of the MRSA clone t304/ST6 in Northern Europe. Clin Microbiol Infect. 2021;27(2):284.e1–284.e5. doi:10.1016/j.cmi.2020.05.004
   PubMed Web of Science ®Google Scholar
• Masimen MAA, Harun NA, Maulidiani M, Ismail WIW. Overcoming methicillin-resistance Staphylococcus aureus (MRSA) using antimicrobial peptides-silver nanoparticles. Antibiotics. 2022;11(7). doi:10.3390/antibiotics11070951
   Google Scholar
• Umar Zango U, Ibrahim M, Abdurrahman Abubakar Shawai S, Muhammad Shamsuddin I. A review on β-lactam antibiotic drug resistance. MOJ Drug Des Develop Ther. 2019. doi:10.15406/mojddt.2019.03.00080
   Google Scholar
• Ba X, Harrison EM, Edwards GF, et al. Novel mutations in penicillin-binding protein genes in clinical Staphylococcus aureus isolates that are methicillin resistant on susceptibility testing, but lack the mec gene. J Antimicrob Chemother. 2014;69(3):594–597. doi:10.1093/jac/dkt418
   PubMed Web of Science ®Google Scholar
• Figueiredo AMS. What is behind the epidemiological difference between community-acquired and health-care associated methicillin-resistant Staphylococcus aureus? Virulence. 2017;8(6):640–642. doi:10.1080/21505594.2017.1335847
   PubMed Web of Science ®Google Scholar
• Safdari H, Aryan E, Sadeghian H, Shams SF, Aganj M. Frequency of methicillin-resistant Staphylococcus aureus (MRSA) in nose and cellular phone of medical and non-medical personnel of emergency departments of Ghaem hospital in Mashhad city. Clin Epidemiol Glob Health. 2020;8(4):1043–1046. doi:10.1016/j.cegh.2020.03.017
   Web of Science ®Google Scholar
• Henderson A, Nimmo GR. Control of healthcare- and community-associated MRSA: recent progress and persisting challenges. Br Med Bull. 2018;125(1):25–41. doi:10.1093/bmb/ldx046
   PubMed Web of Science ®Google Scholar
• Rodríguez F, Salinas C, Fernández S, et al. Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) clones from Paraguayan children. J Infect Dev Ctries. 2020;14(3):290–297. doi:10.3855/jidc.12108
   PubMed Web of Science ®Google Scholar
• Weber K. Community-associated methicillin-resistant Staphylococcus aureus infections in the athlete. Sports Health. 2009;1(5):405–410. doi:10.1177/1941738109343653
   PubMedGoogle Scholar
• Mahmoud ERA, Ahmed HAH, Abo-senna ASM, Riad OKM, Abo-Shadi MM. Isolation and characterization of six gamma-irradiated bacteriophages specific for MRSA and VRSA isolated from skin infections. J Radiat Res Appl Sci. 2021;14(1):34–43. doi:10.1080/16878507.2020.1795564
   Web of Science ®Google Scholar
• Mirani ZA, Naz S, Khan F, et al. Antibacterial fatty acids destabilize hydrophobic and multicellular aggregates of biofilm in S. aureus. J Antibio. 2017;70(2):115–121. doi:10.1038/ja.2016.76
   PubMed Web of Science ®Google Scholar
• Cheung GYC, Bae JS, Otto M. Pathogenicity and virulence of Staphylococcus aureus. Virulence. 2021;12(1):547–569. doi:10.1080/21505594.2021.1878688
   PubMed Web of Science ®Google Scholar
• Chen J, Zhou H, Huang J, Zhang R, Rao X. Virulence alterations in Staphylococcus aureus upon treatment with the sub-inhibitory concentrations of antibiotics. J Adv Res. 2021;31:165–175. doi:10.1016/j.jare.2021.01.008
   PubMed Web of Science ®Google Scholar
• Livermore DM. Antibiotic resistance in staphylococci. Int J Antimicrob Agents. 2000;16:3–10. doi:10.1016/S0924-8579(00)00299-5
   PubMed Web of Science ®Google Scholar
• Mancuso G, Midiri A, Gerace E, Biondo C. Bacterial antibiotic resistance: the most critical pathogens. Pathogens. 2021;10:10. doi:10.3390/pathogens10101310
   Web of Science ®Google Scholar
• Samreen AI, Malak HA, Abulreesh HH, Abulreesh HH. Environmental antimicrobial resistance and its drivers: a potential threat to public health. J Glob Antimicrob Resist. 2021;27:101–111. doi:10.1016/j.jgar.2021.08.001
   PubMed Web of Science ®Google Scholar
• Guo Y, Song G, Sun M, Wang J, Wang Y. Prevalence and therapies of antibiotic-resistance in Staphylococcus aureus. Front Cell Infect Microbiol. 2020;10:10. doi:10.3389/fcimb.2020.00107
   PubMed Web of Science ®Google Scholar
• Wu Q, Sabokroo N, Wang Y, Hashemian M, Karamollahi S, Kouhsari E. Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates. Antimicrob Resist Infect Control. 2021;10(1). doi:10.1186/s13756-021-00967-y
   Web of Science ®Google Scholar
• Liu WT, Chen EZ, Yang L, et al. Emerging resistance mechanisms for 4 types of common anti-MRSA antibiotics in Staphylococcus aureus: a comprehensive review. Microb Pathog. 2021;156:104915. doi:10.1016/j.micpath.2021.104915
   PubMed Web of Science ®Google Scholar
• Finks J, Wells E, Dyke TL, et al. Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007. Emerg Infect Dis. 2009;15(6):943–945. doi:10.3201/eid1506.081312
   PubMed Web of Science ®Google Scholar
• Porras G, Chassagne F, Lyles JT, et al. Ethnobotany and the role of plant natural products in antibiotic drug discovery. Chem Rev. 2021;121(6):3495–3560. doi:10.1021/acs.chemrev.0c00922
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). M07-A9: methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard—Ninth edition. Available from: www.clsi.org. Accessed April 12, 2023.
   Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). M100-S22: performance standards for antimicrobial susceptibility tests; susceptibility breakpoints for antimicrobial susceptibility testing—Twenty Eighth edition; 2018. Available from: www.clsi.org. Accessed April 12, 2023.
   Google Scholar
• Guthridge I, Smith S, Law M, Binotto E, Hanson J. Efficacy and safety of intravenous lincosamide therapy in methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2021;65(9). doi:10.1128/AAC.00343-21
   PubMed Web of Science ®Google Scholar
• Phillips C, Wells N, Martinello M, Smith S, Woodman R, Gordon D. Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range. Infect Drug Resist. 2016;87. doi:10.2147/IDR.S107961
   PubMed Web of Science ®Google Scholar
• Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA. Strategies for Clinical Management of MRSA in the Community: summary of an experts’ meeting convened by the centers for disease control and prevention participants in the Centers for Disease Control and Prevention-Convened Experts’ Meeting on Management of MRSA in the Community; 2006. Available from: http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca.html. Accessed April 12, 2023.
   Google Scholar
• Howden BP, Davies JK, Johnson PDR, Stinear TP, Grayson ML. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev. 2010;23(1):99–139. doi:10.1128/CMR.00042-09
   PubMed Web of Science ®Google Scholar
• Harris A. Methicillin-resistant Staphylococcus aureus (MRSA) in adults: prevention and control. Available from: https://www.uptodate.com/contents/methicillin-resistant-staphylococcus-aureus-mrsa-in-adults-prevention-and-control. Accessed November 28, 2022.
   Google Scholar